BioRestorative Therapies, Inc. (BRTX) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 260 transactions totaling $5.5M, demonstrating a bullish sentiment with $5.4M in net insider flow. The most recent transaction on Oct 6, 2025 involved a transaction of 15,625 shares valued at $25.0K.
No significant insider buying has been recorded for BRTX in the recent period.
No significant insider selling has been recorded for BRTX in the recent period.
Based on recent SEC filings, insider sentiment for BRTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $5.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BioRestorative Therapies, Inc. (BRTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading BRTX stock, having executed 260 transactions in the past 90 days. The most active insider is Dale Broadrick (Executive), who has made 109 transactions totaling $3.2M.
Get notified when executives and directors at BRTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Alstodt Lance | Executive | Award | 15,625 | $1.60 | $25.0K | |
| Oct 6, 2025 | Silva Francisco | Executive | Award | 11,719 | $1.60 | $18.8K | |
| Apr 9, 2024 | Silva Francisco | Executive | Purchase | 6,600 | $1.25 | $8.3K | |
| Apr 8, 2024 | Silva Francisco | Executive | Purchase | 476 | $1.13 | $538 | |
| Apr 8, 2024 | Silva Francisco | Executive | Purchase | 1,232 | $1.17 | $1.4K | |
| Mar 18, 2024 | Alstodt Lance | Executive | Payment | 17,633 | $1.39 | $24.5K | |
| Mar 18, 2024 | Silva Francisco | Executive | Payment | 17,193 | $1.39 | $23.9K | |
| Feb 9, 2024 | Broadrick Dale | Executive | Purchase | 86,041 | $1.32 | $113.6K | |
| Feb 8, 2024 | Broadrick Dale | Executive | Purchase | 83,626 | $1.34 | $112.1K | |
| Feb 8, 2024 | Broadrick Dale | Executive | Purchase | 73,959 | $1.25 | $92.4K | |
| Feb 7, 2024 | Broadrick Dale | Executive | Purchase | 36,374 | $1.38 | $50.2K | |
| Dec 1, 2023 | Broadrick Dale | Executive | Sale | 250 | $1.88 | $470 | |
| Nov 27, 2023 | Broadrick Dale | Executive | Sale | 278 | $1.89 | $525 | |
| Sep 15, 2023 | Alstodt Lance | Executive | Purchase | 2,200 | $1.70 | $3.7K | |
| Sep 15, 2023 | Broadrick Dale | Executive | Purchase | 10,000 | $1.66 | $16.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 223 | $5.4M | 87.3% |
Award(A) | 20 | $440.2K | 7.1% |
Exercise (Options)(X) | 2 | $240.0K | 3.9% |
Payment(F) | 6 | $89.9K | 1.4% |
Sale(S) | 5 | $21.3K | 0.3% |
Other(J) | 2 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at BioRestorative Therapies, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 260 transactions totaling $5.4M in purchases versus $21.3K in sales, the net buying activity of $5.4M signals strong executive confidence. Dale Broadrick (Executive) leads the buying activity with $3.2M in transactions across all time.